BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The landscape of Fc-mediated therapies is undergoing a radical
  transformation\, driven by precise Fc-receptor targeting and antibody do
 main modification to unlock new levels of efficacy and safety for unprece
 dented therapeutic potential in oncology and autoimmune disease treatment
 . The 5th Fc-Mediated Function Summit is the essential destination for ex
 perts driving innovation in Fc-receptor targeting and antibody domain mod
 ification.\n\nThis year\, we're evaluating the cutting-edge of Fc biology
  and engineering\, diving deep into the game-changing potential of novel 
 Fc modifications\, bispecific formats\, and targeted effector functions t
 o revolutionize the treatment of cancer\, autoimmune diseases\, and beyon
 d. Hear from the titans of the pharmaceutical industry\, including AbbVie
 \, Novartis\, and UCB as well as innovative biotechs including Seismic Th
 erapeutics\, Paradigm Immunotherapies\, and many more - as they share the
 ir groundbreaking research and strategies for developing more effective\,
  safer\, and long-lasting fc-mediated solutions. The therapeutic potentia
 l of Fc-mediated functions is surging following last year's wave in FDA a
 pprovals from BeiGene's Tevimbra to Genetech's approval of Piasky\, and t
 he pressure is on to continue this success and develop best-in-class trea
 tments.\n\nDon't miss this pivotal opportunity to network with 50+ leadin
 g scientists and drug development experts in the field of Fc-Mediated Fun
 ction\, forge crucial collaborations\, and be part of the solution. The f
 uture of antibody therapeutics is being written now - be a part of it!\n\
 nDate and Time: Tuesday\, 29 July 2025 at 09:00 to Thursday\, 31 July 202
 5 at 17:00\n
DTEND:20250731T170000
DTSTAMP:20260512T234659Z
DTSTART:20250729T090000
LOCATION:Hilton Boston Back Bay\, 40 Dalton Street\, Boston\, Massachusett
 s\, 02115\,
SEQUENCE:0
SUMMARY:The landscape of Fc-mediated therapies is undergoing a radical tra
 nsformation\, driven by precise Fc-receptor targeting and antibody domain
  modifica...
UID:9b749d65-7e90-4673-bebf-fe0f91a7f814
END:VEVENT
END:VCALENDAR